Shigenobu Suzuki

4.0k total citations
85 papers, 2.2k citations indexed

About

Shigenobu Suzuki is a scholar working on Ophthalmology, Oncology and Nephrology. According to data from OpenAlex, Shigenobu Suzuki has authored 85 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Ophthalmology, 22 papers in Oncology and 18 papers in Nephrology. Recurrent topics in Shigenobu Suzuki's work include Ocular Oncology and Treatments (23 papers), Renal Diseases and Glomerulopathies (14 papers) and Chronic Kidney Disease and Diabetes (11 papers). Shigenobu Suzuki is often cited by papers focused on Ocular Oncology and Treatments (23 papers), Renal Diseases and Glomerulopathies (14 papers) and Chronic Kidney Disease and Diabetes (11 papers). Shigenobu Suzuki collaborates with scholars based in Japan, United States and United Kingdom. Shigenobu Suzuki's co-authors include Akihiro Kaneko, Soichiro Miura, Yuichi Kikuchi, Toshihiko Imakiire, Yasuhiko Tomino, Makoto Araie, Aiko Iwase, Makoto Mohri, Takashi Yamane and Noriaki Hemmi and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Kidney International.

In The Last Decade

Shigenobu Suzuki

79 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shigenobu Suzuki Japan 27 751 499 466 463 413 85 2.2k
Jolanta Kowalewska United States 21 79 0.1× 1.2k 2.3× 88 0.2× 445 1.0× 702 1.7× 49 2.4k
Edmund L. Dubois United States 30 226 0.3× 125 0.3× 343 0.7× 225 0.5× 189 0.5× 59 2.7k
Claudia Mendoza‐Pinto Mexico 25 177 0.2× 71 0.1× 117 0.3× 116 0.3× 188 0.5× 100 1.6k
Daniel Goldman United States 25 122 0.2× 74 0.1× 210 0.5× 96 0.2× 453 1.1× 64 2.1k
Matija Tomšič Slovenia 28 42 0.1× 173 0.3× 259 0.6× 555 1.2× 318 0.8× 131 2.8k
Roberta Donadelli Italy 30 70 0.1× 1.8k 3.6× 81 0.2× 325 0.7× 701 1.7× 53 4.2k
Graham Hughes United Kingdom 22 31 0.0× 418 0.8× 611 1.3× 249 0.5× 450 1.1× 49 3.8k
Salvatore D’Angelo Italy 32 243 0.3× 31 0.1× 106 0.2× 252 0.5× 370 0.9× 165 3.1k
Birgitta Sundelin Sweden 29 26 0.0× 628 1.3× 255 0.5× 491 1.1× 605 1.5× 54 2.5k
Bao‐Dong Qin China 25 57 0.1× 71 0.1× 108 0.2× 541 1.2× 540 1.3× 71 3.1k

Countries citing papers authored by Shigenobu Suzuki

Since Specialization
Citations

This map shows the geographic impact of Shigenobu Suzuki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shigenobu Suzuki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shigenobu Suzuki more than expected).

Fields of papers citing papers by Shigenobu Suzuki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shigenobu Suzuki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shigenobu Suzuki. The network helps show where Shigenobu Suzuki may publish in the future.

Co-authorship network of co-authors of Shigenobu Suzuki

This figure shows the co-authorship network connecting the top 25 collaborators of Shigenobu Suzuki. A scholar is included among the top collaborators of Shigenobu Suzuki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shigenobu Suzuki. Shigenobu Suzuki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kato, Takeshi, et al.. (2022). Encorafenib, binimetinib, and cetuximab in BRAF V600E–mutated colorectal cancer: an early post-marketing phase vigilance study. International Journal of Clinical Oncology. 28(1). 139–144. 5 indexed citations
2.
Morimoto, Takeshi, et al.. (2022). A case of retinoblastoma resulting in phthisis bulbi after proton beam radiation therapy. American Journal of Ophthalmology Case Reports. 28. 101715–101715. 2 indexed citations
3.
Murakami, Naoya, et al.. (2019). High‐dose‐rate interstitial brachytherapy for a bulky sebaceous carcinoma of the eyelid: A case report. SHILAP Revista de lepidopterología. 7(10). 1844–1848. 5 indexed citations
4.
Suzuki, Shigenobu, Koji Inaba, Naoya Murakami, et al.. (2019). Radiotherapy for localized sebaceous carcinoma of the eyelid: a retrospective analysis of 83 patients. Journal of Radiation Research. 60(5). 622–629. 8 indexed citations
5.
Suzuki, Shigenobu, et al.. (2017). Related visual impairment to mother-infant interaction and development in infants with bilateral retinoblastoma. European Journal of Oncology Nursing. 28. 28–34. 10 indexed citations
6.
Suzuki, Shigenobu, et al.. (2015). A Prospective Study of Factors Related to Mother-Infant Interaction in One-year-old Infants with Retinoblastoma.. PubMed. 62(4). 103–13. 4 indexed citations
7.
Itô, Junko, Shigenobu Suzuki, Akihiko Yoshida, & Taisuke Mori. (2015). Primary intraocular synovial sarcoma in the post retinal detachment operative state. BMJ Case Reports. 2015. bcr2015209919–bcr2015209919. 4 indexed citations
8.
Ikee, Ryota, Shuzo Kobayashi, Takamitsu Saigusa, et al.. (2006). Impact of Hypertension and Hypertension-Related Vascular Lesions in IgA Nephropathy. Hypertension Research. 29(1). 15–22. 27 indexed citations
9.
Saigusa, Takamitsu, Yuichi Kikuchi, Muneharu Yamada, et al.. (2006). A case of essential thrombocytosis developing nephrotic syndrome and severe endothelial damage. Journal of Nephrology. 19(5). 656–659. 8 indexed citations
10.
Katayama, Yuta, Masahiro Kami, Yukihiro Matsumoto, Naoko Murashige, & Shigenobu Suzuki. (2005). Deep lamellar keratoplasty for corneal perforation due to chronic graft-versus-host disease following allogeneic hematopoietic stem-cell transplantation.. PubMed. 90(3). ECR15–ECR15. 1 indexed citations
11.
Kikuchi, Yuichi, Toshihiko Imakiire, Tatsuyoshi Ikenoue, et al.. (2005). An Adult With Acute Poststreptococcal Glomerulonephritis Complicated by Hemolytic Uremic Syndrome and Nephrotic Syndrome. American Journal of Kidney Diseases. 46(4). e59–e63. 14 indexed citations
12.
Akiyama, Kazuhide, Jiro Numaga, Yutaka Takazawa, et al.. (2004). Case of Optic Nerve Involvement in Metastasis of a Gastrointestinal Stromal Tumor. Japanese Journal of Ophthalmology. 48(2). 166–168. 21 indexed citations
13.
Suzuki, Shigenobu & Akihiro Kaneko. (2004). Management of intraocular retinoblastoma and ocular prognosis. International Journal of Clinical Oncology. 9(1). 1–6. 102 indexed citations
14.
T, Oda, Kazuo Yamakami, Shigenobu Suzuki, et al.. (2004). Glomerular Plasmin-Like Activity in Relation to Nephritis-Associated Plasmin Receptor in Acute Poststreptococcal Glomerulonephritis. Journal of the American Society of Nephrology. 16(1). 247–254. 53 indexed citations
15.
Kikuchi, Yuichi, Ryota Ikee, Noriaki Hemmi, et al.. (2004). Fractalkine and Its Receptor, CX3CR1, Upregulation in Streptozotocin-Induced Diabetic Kidneys. Nephron Experimental Nephrology. 97(1). e17–e25. 45 indexed citations
16.
Suzuki, Shigenobu, Yusuke Suzuki, Yutaka Kobayashi, et al.. (2000). Insertion/deletion polymorphism in ace gene is not associated with renal progression in Japanese patients with IgA nephropathy. American Journal of Kidney Diseases. 35(5). 896–903. 27 indexed citations
17.
Iijima, Toshihiko, Shigenobu Suzuki, Keiko Sekizuka, et al.. (1998). Follow-up study on urinary type IV collagen in patients with early stage diabetic nephropathy. Journal of Clinical Laboratory Analysis. 12(6). 378–382. 30 indexed citations
18.
Takahashi, Kazuo, Takenori Ochiai, Koichi Uchida, et al.. (1995). Pilot study of mycophenolate mofetil (RS-61443) in the prevention of acute rejection following renal transplantation in Japanese patients. RS-61443 Investigation Committee--Japan.. PubMed. 27(1). 1421–4. 55 indexed citations
19.
Suzuki, Shigenobu, Isao Ebihara, Yasuhiko Tomino, & Hiroshi Koide. (1994). Transcriptional activation of matrix genes by transforming growth factor beta 1 in mesangial cells.. PubMed. 1(4). 229–37. 49 indexed citations
20.
Suzuki, Shigenobu, et al.. (1991). Proto-oncogene expression in peripheral blood mononuclear cells in IgA nephropathy. Kidney International. 39(5). 946–953. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jolanta Kowalewska Breakdown of academic impact, for papers by Edmund L. Dubois Breakdown of academic impact, for papers by Claudia Mendoza‐Pinto Breakdown of academic impact, for papers by Daniel Goldman Breakdown of academic impact, for papers by Matija Tomšič Breakdown of academic impact, for papers by Roberta Donadelli Breakdown of academic impact, for papers by Graham Hughes Breakdown of academic impact, for papers by Salvatore D’Angelo Breakdown of academic impact, for papers by Birgitta Sundelin Breakdown of academic impact, for papers by Bao‐Dong Qin
Rankless by CCL
2026